As of 2024-12-14, the EV/EBITDA ratio of Yourgene Health PLC (YGEN.L) is 35.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. YGEN.L's latest enterprise value is 31.98 mil GBP. YGEN.L's TTM EBITDA according to its financial statements is 0.90 mil GBP. Dividing these 2 quantities gives us the above YGEN.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 26.2x | 12.2x |
| Forward P/E multiples | 10.7x - 24.6x | 13.3x |
| Fair Price | (0.17) - 0.25 | (0.12) |
| Upside | -133.1% - -51.2% | -122.8% |
| Date | EV/EBITDA |